K. Birkmeier

One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2010, Clinical Research in Cardiology.

Second‐versus first‐generation “Limus”‐eluting stents in diabetic patients with coronary artery disease: A randomized comparison in setting of ISAR‐TEST‐4 trial

A. Kastrati, J. Mehilli, J. Pache, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Association of uric acid with mortality in patients with stable coronary artery disease.

M. Hadamitzky, A. Kastrati, A. Schömig, 2012, Metabolism: clinical and experimental.

Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial.

A. Kastrati, J. Mehilli, F. Neumann, 2010, European heart journal.

2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Journal of the American College of Cardiology.

CORONARY ARTERY DISEASE Original Studies Second-Versus First-Generation ‘‘Limus’’-Eluting Stents in Diabetic Patients with Coronary Artery Disease: A Randomized Comparison in Setting of ISAR-TEST-4 Trial

A. Kastrati, J. Mehilli, J. Pache, 2013 .